The FDA has accepted for review the New Drug Application for LNZ100 (aceclidine 1.75% ophthalmic solution) for the treatment of presbyopia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback